Trubion Pharmaceuticals, Inc.
|
2401 Fourth Avenue
Suite 1050
Seattle, WA 98121
United States |
| URL: |
http://www.trubion.com |
|
| Formerly known as: |
| GeneCraft Inc. |
 |
| Primary Symbols & Exchanges: |
| TRBN - NASDAQ |
| - Berlin-Bremen Stock Exchange |
|
|
| Primary Industry: |
| Medical Devices & Diagnostics |
|
|
SIC Industry Code:
|
|
NAICS Industry Code:
|
|
Thomson Financial Business Description:
| The Company's principal activity is to create a pipeline product candidates to treat autoimmune disease and cancer. Its product candidates are novel proteins known as single-chain polypeptides and are designed using our SMIP custom drug assembly technology. These product candidates bind to specific antigen targets on a cell's surface that have been clinically validated as important in disease management either by existing products or by potential products in late stage clinical trials. Product candidates offer the potential for safer and more effective therapies than such existing or potential products. It operate only in United States. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Trubion Pharmaceuticals, Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
